Maculas affected by age-related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and Bruch's membrane

Archives of Ophthalmology

Volumn 121, Issue 8, 2003, Pages 1099-1105

  Hahn, Paul ^b   Milam, Ann H ^b   Dunaief, Joshua L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE; DIAMINOBENZIDINE; FERRIC FERROCYANIDE; IRON CHELATING AGENT;

ADULT; AGED; ARTICLE; BRUCH MEMBRANE; CHELATION; CLINICAL ARTICLE; FEMALE; FENTON REACTION; HUMAN; IRON CHELATION; IRON TRANSPORT; MALE; OXIDATIVE STRESS; PATHOGENESIS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA MACULA DEGENERATION; RETINA MACULA LUTEA; STAINING; TISSUE DISTRIBUTION;

3,3'-DIAMINOBENZIDINE; AGED; AGED, 80 AND OVER; BRUCH MEMBRANE; DEFEROXAMINE; FEMALE; HUMANS; IRON; IRON CHELATING AGENTS; MACULA LUTEA; MACULAR DEGENERATION; MALE; PIGMENT EPITHELIUM OF EYE; PRUSSIAN BLUE REACTION;

EID: 0041560975     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.121.8.1099     Document Type: Article

References (24)

1. Klein R, Wang Q, Klein BE, Moss SE, Meuer SM. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci. 1995;36:182-191.
2. Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2000;45: 115-134.
3. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report No. 8. Arch Ophthalmol. 2001;119:1417-1436.
4. Smith MA, Harris PL, Sayre LM, Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci USA. 1997; 94:9866-9868.
5. Milam AH. Immunocytochemical studies of the retina. In: Rakoczy PE, ed. Vision Research Protocols. Totowa, NJ: Humana Press; 2001:71-88. Methods in Molecular Medicine. vol 47.
6. Milam AH. Immunocytochemical studies of the retina. In: Rakoczy PE, ed. Vision Research Protocols. Totowa, NJ: Humana Press; 2001:71-88. Methods in Molecular Medicine. vol 47.
7. Kontoghiorghes GJ, Pattichi K, Hadjigavriel M, Kolnagou A. Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1). Transfus Sci. 2000;23:211-223.
8. Smith MA, Rottkamp CA, Nunomura A, Raina AK, Perry G. Oxidative stress in Alzheimer's disease. Biochim Biophys Acta. 2000;1502:139-144.
9. Frank RN. "Oxidative protector" enzymes in the macular retinal pigment epithelium of aging eyes and eyes with age-related macular degeneration. Trans Am Ophthalmol Soc. 1998;96:635-689.
10. Atwood CS, Moir RD, Huang X, et al. Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem. 1998;273:12817-12826.
11. Johnson LV, Leitner WP, Rivest AJ, Staples MK, Radeke MJ, Anderson DH. The Alzheimer's abeta-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci U S A. 2002;99:11830-11835.
12. Rottkamp CA, Raina AK, Zhu X, et al. Redox-active iron mediates amyloid-beta toxicity. Free Radic Biol Med. 2001;30:447-450.
13. Tawara A. Transformation and cytotoxicity of iron in siderosis bulbi. Invest Ophthalmol Vis Sci. 1986;27:226-236.
14. Vergara O, Ogden T, Ryan S. Posterior penetrating injury in the rabbit eye: effect of blood and ferrous ions. Exp Eye Res. 1989;49:1115-11126.
15. Doly M, Bonhomme B, Vennat JC. Experimental study of the retinal toxicity of hemoglobinic iron. Ophthalmic Res. 1986;18:21-27.
16. Glatt H, Machemer R. Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol. 1982;94:762-773.
17. Yefimova MG, Jeanny JC, Keller N, et al. Impaired retinal iron homeostasis associated with defective phagocytosis in Royal College of Surgeons rats. Invest Ophthalmol Vis Sci. 2002;43:537-545.
18. Hunt RC, Davis AA. Release of iron by human retinal pigment epithelial cells. J Cell Physiol. 1992;152:102-110.
19. Harris ZL, Durley AP, Man TK, Gitlin JD. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc Natl Acad Sci U S A. 1999;96:10812-10817.
20. Vulpe CD, Kuo YM, Murphy TL, et al. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet. 1999;21:195-199.
21. Miyajima H, Nishimura Y, Mizoguchi K, Sakamoto M, Shimizu T, Honda N. Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology. 1987;37:761-767.
22. Morita H, Ikeda S, Yamamoto K, et al. Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family. Ann Neurol. 1995; 37:646-656.
23. Curcio CA, Medeiros NE, Millican CL. Photoreceptor loss in age-related macular degeneration. Invest Ophthalmol Vis Sci. 1996;37:1236-1249.
24. Sarks JP, Sarks SH, Killingsworth MC. Evolution of geographic atrophy of the retinal pigment epithelium. Eye. 1988;2(pt 5):552-577.